Cargando…

The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

BACKGROUND: Neoadjuvant chemotherapy is incrementally applied to remedy locally advanced gastric cancer. However, NACT also enhances the difficulty of laparoscopic lymph node dissection. The objective of our study was to evaluate the safety and feasibility of laparoscopic gastrectomy for locally adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Rui, Liu, Kai, Zhang, Weihan, Yang, Kun, Chen, Xiaolong, Zhao, Linyong, Zhou, Zongguang, Hu, Jiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174009/
https://www.ncbi.nlm.nih.gov/pubmed/35685425
http://dx.doi.org/10.1155/2022/9511066
_version_ 1784722145645953024
author Ge, Rui
Liu, Kai
Zhang, Weihan
Yang, Kun
Chen, Xiaolong
Zhao, Linyong
Zhou, Zongguang
Hu, Jiankun
author_facet Ge, Rui
Liu, Kai
Zhang, Weihan
Yang, Kun
Chen, Xiaolong
Zhao, Linyong
Zhou, Zongguang
Hu, Jiankun
author_sort Ge, Rui
collection PubMed
description BACKGROUND: Neoadjuvant chemotherapy is incrementally applied to remedy locally advanced gastric cancer. However, NACT also enhances the difficulty of laparoscopic lymph node dissection. The objective of our study was to evaluate the safety and feasibility of laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy. METHODS: From July 2017 to December 2019, 153 patients who received neoadjuvant chemotherapy and underwent the subsequent surgical procedure were retrospectively enrolled and analyzed in the Gastrointestinal Surgery Department of West China Hospital. According to surgical methods, all the patients were sectionalized into two groups: laparoscopic assistant gastrectomy (LAG, 77 patients) and traditional open gastrectomy (OG, 76 patients). The demographic parameters, preoperative, surgical, pathological, and neoadjuvant chemotherapy features were compared between the two groups. RESULTS: A total of 153 patients accepted neoadjuvant chemotherapy and surgical resection in our study. There was no statistically significant difference in demographic parameters and preoperative and neoadjuvant chemotherapy characteristics between the two groups. The LAG group illustrated less intraoperative blood loss (91.1 ± 53.1 ml vs. 125.7 ± 116.9 ml, p=0.010) and shorter postoperative hospital stays (7.9 ± 2.1 days vs. 125.7 ± 116.9 days, p=0.009), when compared to the OG group. Moreover, there was no disparity with respect to operative duration, number of harvested lymph nodes, and postoperative complication rates between the two groups. When considering the Clavien–Dindo classification, no statistically significant difference was indicated in all stratifications with regard to postoperative complications. CONCLUSION: Laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy is safe and feasible without increasing postoperative adverse events.
format Online
Article
Text
id pubmed-9174009
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91740092022-06-08 The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer Ge, Rui Liu, Kai Zhang, Weihan Yang, Kun Chen, Xiaolong Zhao, Linyong Zhou, Zongguang Hu, Jiankun J Oncol Research Article BACKGROUND: Neoadjuvant chemotherapy is incrementally applied to remedy locally advanced gastric cancer. However, NACT also enhances the difficulty of laparoscopic lymph node dissection. The objective of our study was to evaluate the safety and feasibility of laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy. METHODS: From July 2017 to December 2019, 153 patients who received neoadjuvant chemotherapy and underwent the subsequent surgical procedure were retrospectively enrolled and analyzed in the Gastrointestinal Surgery Department of West China Hospital. According to surgical methods, all the patients were sectionalized into two groups: laparoscopic assistant gastrectomy (LAG, 77 patients) and traditional open gastrectomy (OG, 76 patients). The demographic parameters, preoperative, surgical, pathological, and neoadjuvant chemotherapy features were compared between the two groups. RESULTS: A total of 153 patients accepted neoadjuvant chemotherapy and surgical resection in our study. There was no statistically significant difference in demographic parameters and preoperative and neoadjuvant chemotherapy characteristics between the two groups. The LAG group illustrated less intraoperative blood loss (91.1 ± 53.1 ml vs. 125.7 ± 116.9 ml, p=0.010) and shorter postoperative hospital stays (7.9 ± 2.1 days vs. 125.7 ± 116.9 days, p=0.009), when compared to the OG group. Moreover, there was no disparity with respect to operative duration, number of harvested lymph nodes, and postoperative complication rates between the two groups. When considering the Clavien–Dindo classification, no statistically significant difference was indicated in all stratifications with regard to postoperative complications. CONCLUSION: Laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy is safe and feasible without increasing postoperative adverse events. Hindawi 2022-05-31 /pmc/articles/PMC9174009/ /pubmed/35685425 http://dx.doi.org/10.1155/2022/9511066 Text en Copyright © 2022 Rui Ge et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ge, Rui
Liu, Kai
Zhang, Weihan
Yang, Kun
Chen, Xiaolong
Zhao, Linyong
Zhou, Zongguang
Hu, Jiankun
The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title_full The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title_fullStr The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title_full_unstemmed The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title_short The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
title_sort safety and feasibility of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174009/
https://www.ncbi.nlm.nih.gov/pubmed/35685425
http://dx.doi.org/10.1155/2022/9511066
work_keys_str_mv AT gerui thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT liukai thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhangweihan thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT yangkun thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT chenxiaolong thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhaolinyong thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhouzongguang thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT hujiankun thesafetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT gerui safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT liukai safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhangweihan safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT yangkun safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT chenxiaolong safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhaolinyong safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhouzongguang safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer
AT hujiankun safetyandfeasibilityoflaparoscopicgastrectomyafterneoadjuvantchemotherapyforlocallyadvancedgastriccancer